1. Ahnen, DJ, Feigl, P, Quan, G, Fenoglio-Preiser, C, Lovato, L, Bunn, PA Jr, Stemmerman, G, Wells, JD, MacDonald, JJ & Meyskens, FL Jr (1998). Ki-ras mutation and p53 overexpression predict the clinical behaviour of colorectal cancer: a Southwest Oncology Group study. Cancer Res 58: 1149–1158.
2. Auvinen, A, Isola, J, Visakorpi, T, Koivula, T, Virtanen, S & Hakama, M (1994). Overexpression of p53 and long term survival in colon carcinoma. Br J Cancer 70: 293–296.
3. Børresen-Dale, AL, Lothe, RA, Meling, GI, Hainault, P, Torlaiv, OR & Skovlund, E (1998). TP53 and long-term prognosis in colorectal cancer, mutations in the L3 Zn-binding domain predict poor survival. Clin Cancer Res 1: 203–210.
4. Battifora, H (1994). p53 immunochemistry: a word of caution. Hum Pathol 25: 435–436.
5. Bell, S, Scott, N, Cross, D, Sagar, P, Lewis, FA, Blaire, GE, Taylor, GR, Dixon, MF & Quirke, P (1993). Prognostic value of p53 overexpression and c-ki-ras gene mutations in colorectal cancer. Gastroenterology 104: 57–64.